Literature DB >> 24936996

Major depressive disorder (MDD) from the patient's perspective: overcoming barriers to appropriate care.

A Tylee.   

Abstract

Major depressive disorder is a highly stigmatized condition which, despite its prevalence in primary care, is broadly unrecognized and consistently poorly treated. Epidemiological studies reveal a disconcerting lack of understanding about depression within the general population, and this invariably affects patients' attitudes to treatment. Public opinion polls have found a widespread distrust of antidepressant medications, and most members of the public would prefer a psychosocial or alternative approach to treatment to a pharmacological one. Public awareness initiatives such as the UK's Defeat Depression Campaign have helped to positively shift public attitudes towards depression and its treatment, but misconceptions about antidepressant medications appear especially entrenched. The landmark DEPRES study found that over 40% of patients did not consult their doctors for their depression, and only 30% of consulters received an antidepressant. Six clearly differentiated patient clusters were also identified in this study, suggesting that treatment might be selected on the basis of individual symptom profiles and other key differentiating factors. By understanding our patients' perspectives on depression and its management, it should be possible to improve rates of consultation and overcome resistance to antidepressant treatment. Only by achieving both of these goals in parallel will we really be making progress towards optimal management of major depression. ( Int J Psych Clin Pract 2001; 5 (Suppl 1): S37-S42).

Entities:  

Keywords:  Major Depression Patient Perspectives Antidepressants Depres Defeat Depression Campaign

Year:  2001        PMID: 24936996     DOI: 10.1080/13651500152048432

Source DB:  PubMed          Journal:  Int J Psychiatry Clin Pract        ISSN: 1365-1501            Impact factor:   1.812


  5 in total

1.  Study protocol: a dissemination trial of computerized psychological treatment for depression and alcohol/other drug use comorbidity in an Australian clinical service.

Authors:  Frances J Kay-Lambkin; Amanda L Baker; Alison Healey; Samantha Wolfe; Aaron Simpson; Michelle Brooks; Jenny Bowman; Steven Childs
Journal:  BMC Psychiatry       Date:  2012-07-07       Impact factor: 3.630

Review 2.  A systematic review of complex system interventions designed to increase recovery from depression in primary care.

Authors:  Jane Gunn; Justine Diggens; Kelsey Hegarty; Grant Blashki
Journal:  BMC Health Serv Res       Date:  2006-07-16       Impact factor: 2.655

3.  The experience of Greek-Cypriot individuals living with mental illness: preliminary results of a phenomenological study.

Authors:  Charis P Kaite; Maria N Karanikola; Foteini J D Vouzavali; Anna Koutroubas; Anastasios Merkouris; Elizabeth D E Papathanassoglou
Journal:  BMC Psychiatry       Date:  2016-10-06       Impact factor: 3.630

4.  Computerized Cognitive Behavioral Therapy Intervention for Depression Among Veterans: Acceptability and Feasibility Study.

Authors:  Kelly A Stearns-Yoder; Arthur T Ryan; Alexandra A Smith; Jeri E Forster; Sean M Barnes; Lisa A Brenner
Journal:  JMIR Form Res       Date:  2022-04-25

5.  Demonstrating the reliability of transdiagnostic mHealth Routine Outcome Monitoring in mental health services using experience sampling technology.

Authors:  Simone J W Verhagen; Juliënne A Berben; Carsten Leue; Anne Marsman; Philippe A E G Delespaul; Jim van Os; Richel Lousberg
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.